Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program

BACKGROUND: Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of ulcerative colitis (UC). These post hoc analyses assessed associations between C-reactive protein (CRP), partial Mayo score (PMS), and efficacy outcomes during tofacitinib induction in UC. METHODS: Patients receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubinsky, Marla C, Magro, Fernando, Steinwurz, Flavio, Hudesman, David P, Kinnucan, Jami A, Ungaro, Ryan C, Neurath, Markus F, Kulisek, Nicole, Paulissen, Jerome, Su, Chinyu, Ponce de Leon, Dario, Regueiro, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825285/
https://www.ncbi.nlm.nih.gov/pubmed/35380664
http://dx.doi.org/10.1093/ibd/izac061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825285/
https://www.ncbi.nlm.nih.gov/pubmed/35380664
http://dx.doi.org/10.1093/ibd/izac061

Ejemplares similares